0 Comentários
0 Compartilhamentos
452 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Biosimilar Bevacizumab Market – Oncology Cost Reduction and Access ExpansionMarket Overview The biosimilar bevacizumab market is transforming oncology care by offering substantially lower-cost alternatives to reference Avastin while maintaining equivalent efficacy and safety in treating colorectal, lung, breast, and glioblastoma cancers. Bevacizumab inhibits vascular endothelial growth factor, starving tumors of blood supply, but its high cost has limited access in...0 Comentários 0 Compartilhamentos 975 Visualizações 0 Anterior
-
From Bench to Bedside: The Expanding Role of Neuro-Oncology Drugs and CNS Tumor TreatmentThe translation of scientific discoveries into effective therapies for brain tumor patients depends on a robust pipeline of neuro-oncology drugs that can overcome the unique challenges of central nervous system malignancies. Neuro-oncology drugs have emerged as essential tools in this translation, providing the therapeutic agents needed to target tumor cells while minimizing damage to healthy...0 Comentários 0 Compartilhamentos 546 Visualizações 0 Anterior
-
Real World Evidence Solutions For Oncology Market Forecast for Advanced Oncology AnalyticsCancer research has traditionally depended heavily on controlled clinical trials, but the treatment experience that occurs outside those trials is generating an increasingly valuable source of evidence. Patients receive different therapies, move between care settings, respond differently to treatment, and experience outcomes over long periods that may not always be fully captured within...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
The Precision Oncology Frontier: How the Hematological Malignancies Disease Market Is Advancing Blood Cancer CareBlood cancers, including leukemia, lymphoma, and myeloma, represent a significant and growing global health challenge. However, the treatment landscape for these malignancies is undergoing a profound transformation, moving from traditional chemotherapy towards more precise, targeted, and immune-based therapies. The Hematological Malignancies Disease Market, valued at USD 29.6 Billion in 2025,...0 Comentários 0 Compartilhamentos 715 Visualizações 0 Anterior
-
A Critical Barrier: How Oncology Safety Equipment Is Enhancing Cancer CareOncology safety equipment is an essential component of cancer care, ensuring that healthcare workers can deliver chemotherapy and other treatments safely and effectively. This equipment, including chemotherapy gowns, gloves, and closed-system transfer devices, protects healthcare professionals from the hazardous drugs they handle daily, supporting their health and well-being. According to...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Advanced Cardiology and Oncology Treatment Infrastructure Attracting International PatientsEquipping private hospital centers with state-of-the-art cardiovascular and cancer treatment facilities is expanding Malaysia's capacity for complex tertiary healthcare delivery. Detailed analysis within the Malaysia Medical Tourism Market report indicates that interventional cardiology procedures, coronary artery bypass grafting (CABG), robotic prostatectomies, and targeted radiotherapy...0 Comentários 0 Compartilhamentos 356 Visualizações 0 Anterior
-
Advancing Canine Mast Cell Tumors Treatment: The Growing Veterinary Oncology MarketThe field of veterinary oncology has witnessed remarkable progress in recent years, with increased attention focused on the diagnosis and treatment of cancer in companion animals. Among the most common and challenging cancers in dogs are mast cell tumors, which represent a significant area of focus for veterinary oncologists and pharmaceutical developers. The canine mast cell...0 Comentários 0 Compartilhamentos 691 Visualizações 0 Anterior
-
Advancing PD-1 Inhibitor Therapy: The Growing Immuno-oncology Drugs MarketThe field of oncology has been revolutionized by the development of immuno-oncology drugs, with PD-1 inhibitors emerging as a cornerstone of cancer treatment. Tislelizumab, a novel PD-1 inhibitor, offers a targeted approach to immunotherapy, enhancing the body's immune response against cancer cells. The PD-1 inhibitor therapy market is experiencing remarkable growth, with projections...0 Comentários 0 Compartilhamentos 535 Visualizações 0 Anterior
-
AI in Oncology Market Trends: Digital Pathology and AI-Powered Cancer AnalysisPolaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers...0 Comentários 0 Compartilhamentos 461 Visualizações 0 Anterior
-
Anti-CD31 Antibody: Advancing Research and Diagnostics in Vascular Biology and OncologyThe Anti-Cd31 Antibody Market represents a specialized segment of the life sciences research and diagnostics industry, driven by the critical role of CD31 as a marker for endothelial cells, angiogenesis, and vascular biology. This market encompasses monoclonal and polyclonal antibodies, conjugated and unconjugated formats, and associated reagents designed to support applications including...0 Comentários 0 Compartilhamentos 378 Visualizações 0 Anterior
-
Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market – Targeted Apoptosis Therapy Advancing Oncology CareMarket Overview Cancer treatment continues to advance through therapies that restore the body's natural cell death mechanisms in malignant cells. The Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market is growing as oncologists incorporate Bcl-2 inhibitor therapies into treatment regimens for hematologic malignancies where cancer cells evade normal apoptotic signaling. Hematology-oncology centers...0 Comentários 0 Compartilhamentos 685 Visualizações 0 Anterior
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Advances in Targeted Cancer Therapies Create New Opportunities for Market PlayersThe increasing global prevalence of cancer, growing adoption of targeted therapies, and continuous advancements in pharmaceutical research are driving the global Oncology Drugs Market. Oncology drugs play a critical role in cancer treatment by targeting cancer cells, slowing disease progression, and supporting improved patient outcomes. These medicines include chemotherapy, targeted therapy,...0 Comentários 0 Compartilhamentos 104 Visualizações 0 Anterior
-
Antibodies Market Expands as Pharmaceutical R&D Investment RisesThe Antibodies Market is projected to grow from USD 256.1 billion in 2026 to USD 489.8 billion by 2036 at a 6.7% CAGR. ROCKVILLE, MD — October 6, 2026 — The Antibodies Market is projected to reach USD 489.8 billion by 2036, rising from USD 256.1 billion in 2026 at a CAGR of 6.7%, according to Fact.MR. The market was valued at approximately USD 240.0 billion in 2025 and is expected...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Artificial Intelligence in Precision Medicine Market Outlook Through 2033The Artificial Intelligence in Precision Medicine Market is entering a high-growth phase as healthcare providers and pharmaceutical companies increasingly use AI to understand disease biology, predict treatment responses, and develop therapies tailored to individual patients. Artificial Intelligence in Precision Medicine Market Valued at USD 2.4 billion in 2025, the market is projected to...0 Comentários 0 Compartilhamentos 755 Visualizações 0 Anterior
-
Best Thyroid Cancer Treatment in Pakistan - Advanced Diagnosis, Specialist Care and Comprehensive Treatment in Lahore, Karachi and Islamabad.Best Thyroid Cancer Treatment in Pakistan - Advanced Diagnosis, Specialist Care and Comprehensive Treatment in Lahore, Karachi and Islamabad. Best Thyroid Cancer Treatment in Pakistan- Lahore, Karachi or Islamabad is an important search for patients and families looking for reliable cancer care, experienced specialists, and modern treatment facilities. Thyroid cancer develops in the thyroid...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Bevacizumab Market Outlook: Key Trends & Future GrowthAccording to the latest report published by Data Bridge Market Research, the Coal Tar Market CAGR ValueThe coal tar market size was valued at USD 16.54 billion in 2024 and is expected to reach USD 20.47 billion by 2032, at a CAGR of 2.70% during the forecast period. The large scale Coal Tar Market report evaluates CAGR value fluctuation during the forecast period for the market. All the...0 Comentários 0 Compartilhamentos 155 Visualizações 0 Anterior
-
Bevacizumab Market: Growth Drivers, Trends & Emerging OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Bevacizumab Market CAGR ValueData Bridge Market Research analyses that the market, which was USD 6,679.14 million in 2022, would rocket up to USD 12,967.08 million by 2030 and is expected to undergo a CAGR of 9.20% during the forecast period. A talented team works strictly with their potential capabilities to...0 Comentários 0 Compartilhamentos 92 Visualizações 0 Anterior
-
Breakthrough Drug Developments Creating New Opportunities in Immuno OncologyThe North America Immuno-Oncology Drugs Market is expanding as advances in immunology and biotechnology contribute to the development of innovative cancer therapies. Researchers are investigating treatments that enhance immune responses, overcome tumor immune evasion, and improve therapeutic outcomes for selected patient populations. Increasing clinical trial activity, pharmaceutical research...0 Comentários 0 Compartilhamentos 439 Visualizações 0 Anterior
Páginas impulsionada